PTGS2 and oral cavity squamous cell carcinoma: Similarly, Tołoczko-Iwaniuk, studying oral squamous cell carcinoma, demonstrated that a COX-2 inhibitor, celecoxib, leads to apoptosis through increased levels of POX/PRODH [35].